LINDSAY GINTER: Open Payments
NPI 1780207969 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,113 in 98 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $645 · 2025 $2,113
Food & beverage: $2,071Education: $43
| Company | Payments | Amount |
|---|---|---|
| Mannkind Corporation | 11 | $337 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 14 | $264 |
| Amgen Inc. | 12 | $247 |
| Corcept Therapeutics | 16 | $239 |
| Medtronic, Inc. | 15 | $229 |
| RECORDATI_RARE_DISEASES_INC. | 8 | $224 |
| Lilly USA, LLC | 4 | $167 |
| SANOFI-AVENTIS U.S. LLC | 4 | $87 |
| Novo Nordisk Inc | 3 | $74 |
| Verity Pharmaceuticals Inc. | 2 | $51 |
Products named: AFREZZA, JARDIANCE, Korlym, ISTURISA, TEPEZZA, MINIMED 780G, ZEPBOUND, TZIELD.
Industry payments across NV — which companies pay providers there.
